Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-12-10
1994-06-28
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514458, 549399, 549401, 549402, 549405, 549407, 549408, A61K 3135, C07D31158
Patent
active
053247434
ABSTRACT:
This invention provides certain 1,2,4,5 substituted benzene derivatives containing "acid" substituents derived from cyclic or heterocyclic moieties. These unique compounds are leukotriene B.sub.4 antagonists and formulations of these derivatives, and a method of using these derivatives for the treatment of conditions characterized by an excessive release of leukotrienes.
REFERENCES:
patent: 4565882 (1986-01-01), Miyano et al.
patent: 4785017 (1988-11-01), Cohen et al.
patent: 4788214 (1988-11-01), Cohen et al.
patent: 4789903 (1988-10-01), Miyano et al.
patent: 4889871 (1989-12-01), Djuric et al.
patent: 4931574 (1990-06-01), Manchand et al.
patent: 4945099 (1990-07-01), Bollinger et al.
patent: 5003090 (1991-03-01), Marchand et al.
patent: 5124350 (1992-06-01), Djuric et al.
Dillard Robert D.
Sawyer J. Scott
Sofia Michael J.
Benjamin Roger S.
Boone David E.
Cintins Marianne M.
Dahling Gerald V.
Eli Lilly and Company
LandOfFree
Leukotriene B.sub.4 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leukotriene B.sub.4 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leukotriene B.sub.4 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2377642